193 related articles for article (PubMed ID: 35902728)
1. Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner.
Woods ML; Weiss A; Sokol AM; Graumann J; Boettger T; Richter AM; Schermuly RT; Dammann RH
Cancer Gene Ther; 2022 Dec; 29(12):1975-1987. PubMed ID: 35902728
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer.
Ding LY; Hou YC; Kuo IY; Hsu TY; Tsai TC; Chang HW; Hsu WY; Tsao CC; Tian CC; Wang PS; Wang HC; Lee CT; Wang YC; Lin SH; Hughes MW; Chuang WJ; Lu PJ; Shan YS; Huang PH
Clin Epigenetics; 2020 Jun; 12(1):87. PubMed ID: 32552862
[TBL] [Abstract][Full Text] [Related]
3. The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.
Haag T; Herkt CE; Walesch SK; Richter AM; Dammann RH
Genes Cancer; 2014 Sep; 5(9-10):365-74. PubMed ID: 25352953
[TBL] [Abstract][Full Text] [Related]
4. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
Zhang MY; Wang LQ; Chim CS
Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
[TBL] [Abstract][Full Text] [Related]
5. Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells.
Pappano WN; Zhang Q; Tucker LA; Tse C; Wang J
BMC Cancer; 2014 Jun; 14():430. PubMed ID: 24927813
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma.
Ma S; Rubin BP
Lab Invest; 2014 Apr; 94(4):430-8. PubMed ID: 24589855
[TBL] [Abstract][Full Text] [Related]
7. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer.
Murakami K; Kita Y; Sakatani T; Hamada A; Mizuno K; Nakamura K; Takada H; Matsumoto K; Sano T; Goto T; Akamatsu S; Saito R; Tsuruyama T; Ogawa O; Kobayashi T
Cancer Sci; 2021 Sep; 112(9):3669-3681. PubMed ID: 34212455
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of AATK mediates microRNA-558-induced resistance of A549 cells to radiotherapy.
Zhu RX; Song CH; Yang JS; Yi QT; Li BJ; Liu SH
Mol Med Rep; 2016 Sep; 14(3):2846-52. PubMed ID: 27485693
[TBL] [Abstract][Full Text] [Related]
10. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Intronic miR-338-3p and Its Hosting Gene AATK to Compensatory β-Cell Mass Expansion.
Jacovetti C; Jimenez V; Ayuso E; Laybutt R; Peyot ML; Prentki M; Bosch F; Regazzi R
Mol Endocrinol; 2015 May; 29(5):693-702. PubMed ID: 25751313
[TBL] [Abstract][Full Text] [Related]
12. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.
Ding Q; Grammer JR; Nelson MA; Guan JL; Stewart JE; Gladson CL
J Biol Chem; 2005 Feb; 280(8):6802-15. PubMed ID: 15557280
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma.
Chilà R; Basana A; Lupi M; Guffanti F; Gaudio E; Rinaldi A; Cascione L; Restelli V; Tarantelli C; Bertoni F; Damia G; Carrassa L
Oncotarget; 2015 Feb; 6(5):3394-408. PubMed ID: 25428911
[TBL] [Abstract][Full Text] [Related]
14. Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.
Wu S; Wang S; Gao F; Li L; Zheng S; Yung WKA; Koul D
Neuro Oncol; 2018 Jan; 20(1):78-91. PubMed ID: 29016926
[TBL] [Abstract][Full Text] [Related]
15. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells.
Ma HB; Huang S; Yin XR; Zhang Y; Di ZL
World J Gastroenterol; 2014 Jan; 20(1):193-203. PubMed ID: 24415872
[TBL] [Abstract][Full Text] [Related]
17. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
Osman AA; Monroe MM; Ortega Alves MV; Patel AA; Katsonis P; Fitzgerald AL; Neskey DM; Frederick MJ; Woo SH; Caulin C; Hsu TK; McDonald TO; Kimmel M; Meyn RE; Lichtarge O; Myers JN
Mol Cancer Ther; 2015 Feb; 14(2):608-19. PubMed ID: 25504633
[TBL] [Abstract][Full Text] [Related]
18. A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinase.
Kos A; Olde Loohuis NF; Wieczorek ML; Glennon JC; Martens GJ; Kolk SM; Aschrafi A
PLoS One; 2012; 7(2):e31022. PubMed ID: 22363537
[TBL] [Abstract][Full Text] [Related]
19. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.
Schumm K; Rocha S; Caamano J; Perkins ND
EMBO J; 2006 Oct; 25(20):4820-32. PubMed ID: 16990795
[TBL] [Abstract][Full Text] [Related]
20. Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor.
Mizuarai S; Yamanaka K; Itadani H; Arai T; Nishibata T; Hirai H; Kotani H
Mol Cancer; 2009 Jun; 8():34. PubMed ID: 19500427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
